$0.0037
+0 (+0%)
At Close: Jun 22, 2026
PharmaDrug files Orphan Drug Designation with US FDA for the use of DMT in kidney transplants
09:39am, Thursday, 25'th Feb 2021
PharmaDrug Inc (CSE:BUZZ) (OTCPINK:LMLLF) announced Thursday it had filed an application with the US Food and Drug Administration to receive an orphan drug designation for the use of DMT in preventing
PharmaDrug Files For FDA Orphan Drug Designation For DMT In Kidney Transplantation and Expands on Its Psychedelics Strategy
07:33am, Thursday, 25'th Feb 2021
Toronto, Ontario--(Newsfile Corp. - February 25, 2021) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, deve
PharmaDrug Inc. (CSE:BUZZ) (OTCMKTS:LMLLF) said it has filed an Orphan Drug Designation (ODD) application with the US Food and Drug Administration (FDA) for the use of psychedelic drug N,N-Dimethyltry
PharmaDrug looking to develop and commercialise a range of psychedelics, cannabis and naturally-derived drugs
07:59am, Wednesday, 10'th Feb 2021
Owns 80% of Pharmadrug GmbH, a German medical cannabis distributor Owns 100% of Super Smart, a Dutch company building a modern adult-use psychedelic retail business Recently acquired Sairiyo Therapeut
PharmaDrug Inc (CSE:BUZZ) (OTCPINK:LMLLF) has appointed world-renowned chemist and neuroscientist Dr Steven Barker to the company's newly formed scientific advisory board for psychedelic pharmaceutica
Toronto, Ontario--(Newsfile Corp. - February 8, 2021) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, devel
Fast-paced PharmaDrug looks to create winning formula with cannabis, psychedelics and biotechnology
02:54pm, Sunday, 07'th Feb 2021
PharmaDrug Inc (CSE:BUZZ) (OTC:LMLLF) encompasses almost all the facets of the evolving medical cannabis and psychedelics industry. In one package you have a business that is involved in THC, CBD and
PharmaDrug Grants Stock Options
04:30pm, Friday, 05'th Feb 2021
Toronto, Ontario--(Newsfile Corp. - February 5, 2021) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company") announces the grant of stock options to directors, officers and co
PharmaDrug Signs Supply Agreement with Global Cannabis Supplier and Provides Update on German Operations and Balance Sheet Improvements
08:23am, Thursday, 04'th Feb 2021
Toronto, Ontario--(Newsfile Corp. - February 4, 2021) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company") has entered into a supply agreement (the "Supply Agreement") on J
Toronto, Ontario--(Newsfile Corp. - January 25, 2021) - PharmaDrug Inc. (CSE: BUZZ) (OTC: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the development and comm
Sign In
Buy LMLLF